Skip to content
Save up to 80% Fast & Discrete Delivery
Estrace
Quality products
Fast & Discrete Delivery
Money-back guarantee

Estrace

4.2 (3 customer reviews)
Delivery: 4-7 business days
Payment
24/7 Support
Active ingredient: Estradiol

Free bonus tablets with every order: 4 on any order, 8 over $112.00, 12 over $222.88, 16 over $334.88

256-bit SSL
Certified pharmacy
Money-back guarantee

Estrace is prescribed for women with moderate to severe menopausal symptoms, including hot flashes and vaginal discomfort. It replaces estrogen that declines after menopause and also helps limit postmenopausal bone loss.

Overview

Estradiol, the active ingredient of Estrace, is a bioidentical estrogen used in menopausal hormone therapy.

Therapeutic indications

Management of Menopausal Symptoms

Menopause-related hot flashes and night sweats develop partly because reduced estrogen affects temperature-control pathways in the hypothalamus. Small shifts in body temperature can then trigger sudden heat, flushing, perspiration, and sleep interruption. Estradiol can widen that temperature-neutral zone and reduce the frequency or intensity of vasomotor symptoms.

Vaginal dryness, burning, itching, pain during sex, and urinary discomfort may reflect genitourinary syndrome of menopause. Estrogen loss makes vaginal tissue thinner, less elastic, and less able to maintain normal moisture and acidity. Estradiol supports maturation of vaginal epithelial cells and can improve tissue resilience over time.

Vasomotor Symptom Reduction

In clinical practice, women often describe the first benefit as fewer night sweats or waking less often drenched in sweat. Sleep may improve secondarily when repeated overnight temperature surges settle.

Hormone therapy remains the most effective treatment for bothersome vasomotor symptoms in appropriately selected menopausal women, according to the North American Menopause Society. [2]

Restoration of Urogenital Integrity

Estradiol supports blood flow, collagen formation, and glycogen-rich vaginal cells. Glycogen helps support lactobacilli, bacteria that contribute to a healthy vaginal environment. This can reduce friction-related discomfort and may ease recurrent irritation linked to postmenopausal tissue changes.

Practical tip: symptom improvement is often gradual. Keep brief notes on hot flashes, night waking, vaginal comfort, and any unexpected bleeding during the first months of treatment.
Estradiol approach Main symptom focus Clinical use pattern
Systemic estradiol Hot flashes, night sweats, bone loss prevention Used when symptoms extend beyond vaginal tissues
Local vaginal estradiol Dryness, burning, painful intercourse Used when symptoms are mainly vaginal or urinary

How it affects the body

Estradiol enters cells and binds to estrogen receptors, mainly estrogen receptor alpha and estrogen receptor beta. These receptors influence gene activity in tissues such as the brain, vagina, skin, bone, breasts, liver, and uterus. The result is not an instant symptom switch; hormone-responsive tissues gradually change their signaling and tissue maintenance patterns. The FDA describes estradiol as systemic estrogen therapy for approved menopausal indications. Clinical response varies according to the treatment route, dose, symptoms, and individual medical history. [1]

Pharmacological Profile of Estradiol

Estrogen receptors act like cellular control points. Once estradiol binds to them, the receptor complex can alter production of proteins involved in temperature regulation, vaginal lubrication, collagen maintenance, and bone remodeling.

Estrace is a prescription hormone treatment, not a general wellness supplement.

Reasons not to use it

Estrace is not for you if you have undiagnosed abnormal genital bleeding, known or suspected estrogen-dependent cancer, active or previous blood clots, stroke, heart attack, liver disease, or a known serious allergy to estradiol.

Medicines that induce liver enzymes, such as carbamazepine, phenytoin, rifampin, and St. John’s wort, may reduce estradiol exposure. Some antifungals, macrolide antibiotics, and HIV medicines may increase estrogen exposure. Grapefruit can also affect estrogen metabolism in some people.

When this is not for you

It is also unsuitable during pregnancy. People with a history of breast cancer, endometrial cancer, migraine with aura, high triglycerides, gallbladder disease, systemic lupus erythematosus, or hereditary clotting disorders need individualized prescribing decisions.

Possible side effects

Common effects can include breast tenderness, nausea, headache, bloating, fluid retention, leg cramps, and changes in vaginal discharge. These effects may lessen as the body adjusts, though persistent symptoms should be assessed rather than ignored.

Seek urgent medical care for symptoms suggestive of a clot, stroke, or serious allergic reaction:

  • New chest pain, shortness of breath, or coughing blood
  • Sudden one-sided leg pain, warmth, swelling, or redness
  • Sudden severe headache, fainting, confusion, weakness, or speech difficulty
  • New vision loss or major visual disturbance
  • Swelling of the lips, tongue, or throat

Formulation

Estrace contains estradiol, a form of estrogen that is chemically identical to the main estrogen produced by the ovaries before menopause. It is used when falling estrogen levels cause disruptive vasomotor symptoms, vulvovaginal changes, or increased bone turnover.

Practical tip: the prescribed regimen should be confirmed with a healthcare professional before starting Estrace, especially if you have a uterus, a history of migraines, or use medicines that affect blood clotting.

Dosage and administration

  • Dose: Administer the prescribed Estrace strength; the exact amount in mg or mL is confirmed with a healthcare professional before starting.
  • Frequency: Follow the prescribed number of administrations per day; the frequency for the chosen strength is confirmed with a healthcare professional.
  • Timing: Follow the prescribed time of day and meal instructions; these instructions are confirmed with a healthcare professional.
  • Duration: Continue for the prescribed duration, with the treatment period confirmed with a healthcare professional.
  • Route: Administer Estrace by the prescribed route; the product form and route are confirmed with a healthcare professional.

Comparison

Estrace uses bioidentical estradiol, meaning its molecular structure matches endogenous human estradiol. Synthetic estrogens and conjugated equine estrogens differ in chemical composition and receptor activity. Phytoestrogens are plant compounds with weak estrogen-like activity and do not provide the same predictable therapeutic effect as prescribed estradiol.

Approach Estrogen activity Limitation
Estrace with estradiol Direct estrogen receptor activation Requires assessment of estrogen-related risks
Synthetic or conjugated estrogens Systemic estrogen activity through different estrogen mixtures Side-effect and metabolic profiles differ by formulation
Phytoestrogens Weak, variable estrogen-like activity Evidence for significant symptom relief is inconsistent

The EMA and other major medicines regulators treat menopausal hormone therapy as individualized care rather than a one-size-fits-all approach. Route, uterine status, symptom burden, age, and clotting history shape the choice of therapy. [5]

Common mistakes

Several avoidable issues can make estradiol therapy less successful or less safe:

  • Starting without confirming whether progesterone or a progestin is needed for endometrial protection.
  • Ignoring postmenopausal bleeding because it seems minor.
  • Stopping suddenly after long-term use and being surprised by a return of hot flashes.
  • Omitting a complete medication list, including seizure medicines, antibiotics, antifungals, and herbal products.
  • Treating new calf pain, chest symptoms, or sudden neurologic symptoms as unrelated discomfort.
  • Using estrogen to manage symptoms while overlooking sleep, activity, smoking, and alcohol habits that can intensify hot flashes.
Practical tip: keep one updated medication list that includes prescriptions, over-the-counter pain relievers, vitamins, and herbal products. Estradiol interaction checks are far more accurate when the whole list is available.

What doctors say

Clinicians usually focus first on the symptom pattern. Frequent hot flashes, night sweats that disrupt sleep, painful intercourse related to vaginal atrophy, and rapid bone loss after menopause point toward different treatment goals.

A common clinical mistake is expecting estrogen to improve every symptom immediately. Hot flashes may improve before sleep and mood recover, while vaginal tissue changes may take longer to become noticeable. Doctors also look for new bleeding, persistent breast pain, severe headaches, blood-pressure changes, and clot symptoms at follow-up visits.

The aim is the lowest effective estrogen exposure for the shortest duration consistent with the treatment goal, with periodic reassessment of whether therapy remains appropriate.

Common questions

What happens if I stop Estrace, and should it be tapered?

Stopping Estrace can allow hot flashes, night sweats, sleep disruption, or vaginal symptoms to return. Some women stop without major difficulty, while others experience a recurrence within weeks or months. The FDA's 2012 prescribing information recognizes that estrogen treatment should be reassessed periodically, and a clinician may suggest gradual dose reduction for women who have used systemic therapy for a prolonged period. Tapering does not guarantee that symptoms will not return, but it can make the transition easier for some patients.

Which symptoms mean I should stop Estrace and seek urgent medical care?

Sudden chest pain, shortness of breath, coughing blood, one-sided leg swelling, sudden weakness, severe headache, speech changes, or vision loss need urgent assessment because they can signal a clot, stroke, or other serious event. New postmenopausal vaginal bleeding also needs prompt evaluation because unopposed estrogen can stimulate the endometrium. The FDA's 2012 warning information for estradiol lists thrombotic and cardiovascular risks that warrant attention. Do not restart treatment after a serious suspected reaction until a clinician has assessed the cause.

How should Estrace be stored at home and while traveling?

Store Estrace at controlled room temperature, away from excess heat, moisture, and direct sunlight. A bathroom cabinet can be a poor choice because steam and temperature swings are frequent. During travel, keep the medicine in a secure carry-on bag rather than leaving it in a hot vehicle or checked luggage. The FDA's 2012 Estrace labeling emphasizes protecting the medicine from heat, humidity, and accidental access by children.

What should I do after a missed dose of Estrace?

Take the missed dose when remembered unless it is close to the next planned dose. If the next dose is near, skip the missed dose and resume the usual schedule. Do not take two doses together to compensate, because doubling estrogen exposure can increase nausea, breast tenderness, headache, or breakthrough bleeding. The 2012 FDA prescribing information provides the product-specific dosing framework, while a healthcare professional should confirm the regimen because plans vary by indication and individual medical history.

Which diet, exercise, and habits can help or hinder Estrace results?

Regular physical activity supports bone strength, sleep quality, mood, and cardiovascular health during menopause. Smoking can worsen hot flashes and is linked to a higher risk of cardiovascular disease and blood clots, which matters when evaluating estrogen therapy. Alcohol, spicy foods, hot drinks, and warm bedrooms trigger hot flashes for some women, so a symptom diary can identify personal patterns. The 2024 NICE menopause guidance supports lifestyle measures alongside treatment choices, while recognizing that they do not replace indicated therapy for significant symptoms.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in.) and its contents cannot be seen.

Prevention of Postmenopausal Osteoporosis

Estrogen decline accelerates bone remodeling after menopause. Osteoclasts, the cells that break down old bone, can become more active than osteoblasts, the cells that build new bone. Over time, this imbalance lowers bone mineral density and raises fracture risk.

Estradiol slows excessive osteoclast activity and helps preserve bone mass. Estrace may be prescribed for prevention of postmenopausal osteoporosis when non-estrogen options are unsuitable and the individual risk-benefit assessment supports hormone therapy.

Bone protection is a meaningful benefit, though estrogen is not automatically the first choice for every woman at fracture risk. The U.S. Preventive Services Task Force advises against using systemic hormone therapy solely to prevent chronic conditions in postmenopausal women because treatment decisions must account for risks as well as benefits. [3]

Practical tip: resistance exercise, regular walking or impact activity when medically appropriate, adequate protein, calcium-rich foods, and vitamin D status all remain relevant while using estrogen therapy.

Integration Within Hormone Replacement Therapy

Hormone Replacement Therapy, often shortened to HRT or menopausal hormone therapy, can use estradiol through oral, transdermal, or vaginal routes. The best route depends on the symptoms being treated, medical history, and whether systemic estrogen exposure is needed.

Estrace provides estradiol therapy. Transdermal estradiol patches and gels deliver estrogen through the skin, while vaginal estradiol products are directed toward local urogenital symptoms. Oral estrogen undergoes first-pass metabolism in the liver, which may influence triglycerides, clotting proteins, and drug interactions.

Women with an intact uterus usually need a progestin or progesterone alongside systemic estradiol. This protects the endometrium from prolonged estrogen stimulation.

Estrogen modality Delivery route Typical clinical focus
Oral estradiol Taken by mouth Systemic menopausal symptoms and bone-related indications
Transdermal estradiol Patch, gel, or spray on skin Systemic symptoms with avoidance of oral first-pass liver metabolism
Vaginal estradiol Applied inside the vagina Local vaginal and urinary menopausal symptoms
Practical tip: tell the prescriber if you develop leg swelling, recurrent migraine with aura, or gallbladder symptoms after starting estrogen, since these details can influence the preferred estrogen route.

Safety Profile and Contraindications

Estrace can provide substantial symptom relief, yet systemic estrogen has clinically significant risks. The FDA labeling for estradiol includes warnings about endometrial cancer, cardiovascular events, breast cancer, venous thromboembolism, dementia in certain older women, and gallbladder disease. Risk varies with age, dose, duration, route, concurrent progestin use, and personal medical history. [4]

Endometrial Protection Protocols

Unopposed systemic estrogen stimulates the endometrium, the lining of the uterus. Over time, this may cause endometrial hyperplasia and raise the risk of endometrial cancer. For women who still have a uterus, clinicians commonly add progesterone or a progestin to counterbalance this effect.

Unexpected vaginal bleeding after menopause needs medical assessment. It should not be assumed to be a routine hormone effect, even if bleeding is light or intermittent.

Customer Feedback on Estrace

Lucy, 61
Portland
Several weeks
Verified
Rating: 5 out of 5
I used Estrace for recurring hot flashes that were waking me several times a night. After several weeks, I was sleeping through most nights and could get through morning walks without feeling overheated. The improvement felt steady rather than sudden, and I was satisfied with the change.
Nov 10, 2026
Claire, 28
Milwaukee
First month to the end of the second month
Verified
Rating: 4.5 out of 5
I took Estrace for low-estrogen symptoms following treatment that affected my ovarian function. The dry, irritated feeling improved, and I was more comfortable during everyday activities within the first month. I felt like myself again by the end of the second month.
Oct 15, 2026
Hannah, 58
San Antonio
First few weeks
Verified
Rating: 3 out of 5
Estrace reduced my night sweats and the vaginal dryness improved, but I had breast tenderness during the first few weeks. It settled down somewhat, although the adjustment took longer than I expected. I continued after discussing the symptoms and follow-up plan with my doctor.
Oct 29, 2026

Sources

  1. Food and Drug Administration (2012). ESTRACE® (estradiol tablets, USP) prescribing information.
  2. The North American Menopause Society (2022). The 2022 hormone therapy position statement of The North American Menopause Society.
  3. U.S. Preventive Services Task Force (2022). Hormone therapy for the primary prevention of chronic conditions in postmenopausal persons: US Preventive Services Task Force recommendation statement.
  4. Food and Drug Administration (2012). ESTRACE® (estradiol tablets, USP) boxed warning and warnings and precautions.
  5. National Institute for Health and Care Excellence (2024). Menopause: identification and management (NG23).
Get our free app Shop faster and track your orders 4.0 · 266 reviews Install